Overview

Psoriasis Treatment Market is poised to value USD 34258.16 million by 2028 end at a CAGR of 8.7% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Psoriasis Treatment Market  trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Psoriasis Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Psoriasis Treatment Market:
• Merck and Co., Inc.
• LEO Pharma A/S
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd
• AbbVie Inc.
• UCB S.A.
• Amgen Inc.
• Johnson and Johnson Services, Inc.
• Eli Lilly and Company
• Novartis AG
• AstraZeneca plc
• Biogen, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Psoriasis Treatment Market Segmentation:
By Drug Class
• TNF Inhibitors
• Interleukins
• Others

By Type
• Plaque Psoriasis
• Psoriatic Arthritis
• Others

By Route of Administration
• Oral
• Parenteral
• Topical

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online pharmacies

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Psoriasis Treatment Market By Drug Class, By Type, By Route of Administration, By Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Psoriasis Treatment Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Psoriasis Treatment Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Psoriasis Treatment Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Psoriasis Treatment Market, By Drug Class Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. TNF Inhibitors
  7.2. Interleukins
  7.3. Others

8. Psoriasis Treatment Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
  8.1. Plaque Psoriasis
  8.2. Psoriatic Arthritis
  8.3. Others

9. Psoriasis Treatment Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million)
  9.1. Oral
  9.2. Parenteral
  9.3. Topical

10. Psoriasis Treatment Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million)
   10.1. Hospital Pharmacies
   10.2. Retail Pharmacies
   10.3. Online pharmacies

11. North America Psoriasis Treatment Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  11.1. Introduction
  11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       11.2.1. U.S.A
       11.2.2. Canada
       11.2.3. Mexico
  11.3. Market Size (USD Million) Forecast for North America 2022-2028

12. Latin America Psoriasis Treatment Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Brazil
         12.2.2. Venezuela
         12.2.3. Argentina
         12.2.4. Rest of Latin America
   12.3. Market Size (USD Million) Forecast for Latin America 2022-2028

13. Europe Psoriasis Treatment Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Germany
         13.2.2. U.K        
         13.2.3. France
         13.2.4. Italy
         13.2.5. Spain
         13.2.6. Russia
         13.2.7. Poland
         13.2.8. Rest of Europe
   13.3. Market Size (USD Million) Forecast for Europe 2022-2028

14. Asia Pacific Psoriasis Treatment Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. Japan
         14.2.2. China
         14.2.3. India
         14.2.4. Australia and New Zealand
         14.2.5. ASEAN
         14.2.6. Rest of Asia Pacific
   14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         15.2.1. GCC
         15.2.2. Israel
         15.2.3. South Africa
         15.2.4. Rest of MEA
   15.3. Market Size (USD Million) Forecast for MEA 2022-2028

16. Market Share Analysis and Competitive Landscape  
   16.1. Global Landscape - Key Players, Revenue and Presence
   16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   16.3. Global Emerging Companies
   16.4. North America - Market Share Analysis and Key Regional Players
   16.5. Europe - Market Share Analysis and Key Regional Players
   16.6. Asia Pacific - Market Share Analysis and Key Regional Players
   16.7. Global Key Player - Growth Matrix

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   17.1. Merck and Co., Inc.
         17.1.1. Company Overview
         17.1.2. Product Portfolio
         17.1.3. SWOT Analysis
         17.1.4. Financial Overview
         17.1.5. Strategic Overview
   17.2. LEO Pharma A/S
         17.2.1. Company Overview
         17.2.2. Product Portfolio
         17.2.3. SWOT Analysis
         17.2.4. Financial Overview
         17.2.5. Strategic Overview
   17.3. Pfizer Inc.
         17.3.1. Company Overview
         17.3.2. Product Portfolio
         17.3.3. SWOT Analysis
         17.3.4. Financial Overview
         17.3.5. Strategic Overview
   17.4. Sun Pharmaceutical Industries Ltd
         17.4.1. Company Overview
         17.4.2. Product Portfolio
         17.4.3. SWOT Analysis
         17.4.4. Financial Overview
         17.4.5. Strategic Overview
   17.5. TÜV SÜD
         17.5.1. Company Overview
         17.5.2. Product Portfolio
         17.5.3. SWOT Analysis
         17.5.4. Financial Overview
         17.5.5. Strategic Overview          
   17.6. AbbVie Inc.
         17.6.1. Company Overview
         17.6.2. Product Portfolio
         17.6.3. SWOT Analysis
         17.6.4. Financial Overview
         17.6.5. Strategic Overview      
   17.7. UCB S.A.
         17.7.1. Company Overview
         17.7.2. Product Portfolio
         17.7.3. SWOT Analysis
         17.7.4. Financial Overview
         17.7.5. Strategic Overview
   17.8. Amgen Inc.
         17.8.1. Company Overview
         17.8.2. Product Portfolio
         17.8.3. SWOT Analysis
         17.8.4. Financial Overview
         17.8.5. Strategic Overview
   17.9. Johnson and Johnson Services, Inc.
         17.9.1. Company Overview
         17.9.2. Product Portfolio
         17.9.3. SWOT Analysis
         17.9.4. Financial Overview
         17.9.5. Strategic Overview
   17.10.Eli Lilly and Company
         17.10.1.Company Overview
         17.10.2.Product Portfolio
         17.10.3.SWOT Analysis
         17.10.4.Financial Overview
         17.10.5.Strategic Overview
   17.11.Novartis AG
         17.11.1.Company Overview
         17.11.2.Product Portfolio
         17.11.3.SWOT Analysis
         17.11.4.Financial Overview
         17.11.5.Strategic Overview
   17.12.AstraZeneca plc
         17.12.1.Company Overview
         17.12.2.Product Portfolio
         17.12.3.SWOT Analysis
         17.12.4.Financial Overview
         17.12.5.Strategic Overview
   17.13.Biogen, Inc.
         17.13.1.Company Overview
         17.13.2.Product Portfolio
         17.13.3.SWOT Analysis
         17.13.4.Financial Overview
         17.13.5.Strategic Overview

18. Pre and Post COVID-19 Impact
   18.1. Positive influence on the healthcare industry
   18.2. The financial disruption of the manufacturing sector
   18.3. Impact of COVID-19 on emerging companies
   18.4. Significant mandates in the healthcare regulations initiated by administrations
   18.5. The overall economic slowdown of the developing and developed nations

19. FutureWise SME Key Takeaway Points for Client

Tables

Figures